MG01CI extended-release tablet ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
206脆弱X症候群1

206. 脆弱X症候群


臨床試験数 : 108 薬物数 : 91 - (DrugBank : 36) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 77
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02126995
(ClinicalTrials.gov)
June 201429/4/2014A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X SyndromeA 6-week, Randomized, Multicenter, Double-blind, Parallel, Flexed and Fixed-dose Study of MG01CI (Metadoxine Extended-release) Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X SyndromeFragile X SyndromeDrug: MG01CI extended-release tabletAlcobra Ltd.NULLCompleted15 Years55 YearsBoth62Phase 2United States;Israel